Biogen Inc. Human Resources Contracts & Agreements
61 Contracts & Agreements
- Bonus & Incentive Agreements (16 contracts)
- Consulting Agreements (3)
- Employment Agreements (25)
- Separation Agreements (2)
- Severance Agreements (14)
- Transition Agreements (1)
- Letter regarding employment arrangement of Rachid Izzar dated August 1, 2019 (Filed With SEC on February 14, 2024)
- Letter amending employment arrangement of Susan Alexander dated February 28, 2020 (Filed With SEC on February 14, 2024)
- Letter regarding employment arrangement of Nicole Murphy dated January 28, 2022 (Filed With SEC on April 25, 2023)
- Letter regarding employment arrangement of Ginger Gregory dated June 9, 2017 (Filed With SEC on April 25, 2023)
- Employment Agreement, dated November 10, 2022, by and between Biogen Inc. and Christopher A. Viehbacher (Filed With SEC on November 10, 2022)
- Letter regarding employment arrangement of Michel Vounatsos dated May 2, 2022 (Filed With SEC on May 3, 2022)
- Amended and Restated Biogen Inc. 2019 Performance-Based Management Incentive Plan, effective as of June 2, 2021 (Filed With SEC on July 22, 2021)
- Letter regarding employment arrangement of Chirfi Guindo dated October 12, 2017 (Filed With SEC on February 3, 2021)
- Separation Agreement between Biogen Inc. and Jeffrey Capello dated July 16, 2020 (Filed With SEC on October 21, 2020)
- Letter regarding employment arrangement of Michael McDonnell dated July 16, 2020 (Filed With SEC on October 21, 2020)
- Biogen Inc. Executive Severance Policy - U.S. Executive Vice President, as amended effective July 13, 2020 (Filed With SEC on October 21, 2020)
- Biogen Inc. Executive Severance Policy - U.S. Executive Vice President, as amended effective June 19, 2019 (Filed With SEC on July 24, 2019)
- Form of performance stock units award agreement (cash settled) under the Biogen Inc. 2017 Omnibus Equity Plan (for grants commencing in July 2019) (Filed With SEC on July 24, 2019)
- Form of performance stock units award agreement under the Biogen Inc. 2017 Omnibus Equity Plan (for grants commencing in July 2019) (Filed With SEC on July 24, 2019)
- Biogen Inc. 2019 Form of Performance-Based Management Incentive Plan. Filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 (Filed With SEC on April 24, 2019)
- Letter regarding employment arrangement for Paul McKenzie dated December 14, 2015 (Filed With SEC on April 24, 2018)
- Form of performance stock units award agreement (cash settled) under the Biogen Inc. 2017 Omnibus Equity Plan (Filed With SEC on April 24, 2018)
- Form of performance stock units award agreement under the Biogen Inc. 2017 Omnibus Equity Plan (Filed With SEC on April 24, 2018)
- Letter regarding employment arrangement of Michael Ehlers dated April 16, 2016 (Filed With SEC on February 1, 2018)
- Letter regarding employment arrangement of Gregory Covino dated February 25, 2012 (Filed With SEC on February 1, 2018)
- Letter regarding employment arrangement of Jeffrey Capello dated November 14, 2017 (Filed With SEC on February 1, 2018)
- Form of performance stock units award agreement under the Biogen Inc. 2017 Omnibus Equity Plan (Filed With SEC on February 1, 2018)
- Form of performance stock units award agreement (cash-settled) under the Biogen Inc. 2017 Omnibus Equity Plan (Filed With SEC on February 1, 2018)
- CASH-SETTLED PERFORMANCE UNITS AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN (Filed With SEC on July 25, 2017)
- PERFORMANCE UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN (Filed With SEC on July 25, 2017)
- SEPARATION AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. Dated as of January 31, 2017 TABLE OF CONTENTS (Filed With SEC on February 2, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 19, 2016)
- /s/ Alfred SandrockOctober 20, 2015Alfred SandrockSignature Date New Level24New Bonus Target70% of salaryNew PositionEVP, CMO, Neurology & NeurodegenerationReports... (Filed With SEC on February 3, 2016)
- PERFORMANCE UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN (Filed With SEC on April 23, 2014)
- Severance Plan for International Executive Vice Presidents (Filed With SEC on February 6, 2014)
- Severance Plan for U.S. Executive Vice Presidents (Filed With SEC on February 6, 2014)
- PERFORMANCE SHARES AWARD AGREEMENT GRANTED UNDER BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN (Filed With SEC on February 6, 2014)
- EMPLOYMENT AGREEMENT (as amended effective as of July 15, 2013) (Filed With SEC on August 26, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on July 1, 2010)
- EX-10.1 Form of cash-settled performance shares award agreement under the 2008 Omnibus Equity Plan (Filed With SEC on April 20, 2010)
- Ex-10.58 Letter regarding employment arrangement of Susan Alexander dated December 13, 2005 (Filed With SEC on February 9, 2010)
- EX-10.52 Letter regarding employment arrangement of Robert Hamm dated April 1, 2009 (Filed With SEC on February 9, 2010)
- Ex-10.50 Transition Agreement, dated as of January 4, 2010 (Filed With SEC on February 9, 2010)
- Ex-10.1 Consulting Agreement between Eidetica Biopharma GmBH and Hans Peter Hasler dated April 30, 2009 (Filed With SEC on July 17, 2009)
- Ex-10.66 First Amendment to Employment Agreement between Biogen Idec and Craig E. Schneier dated October 8, 2008 (Filed With SEC on February 6, 2009)
